JAMES COLEMAN: Open Payments
NPI 1225758022 · TRINITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$886 in 45 payments from 15 companies in 2025. Trend: 2023 $599 · 2024 $1,421 · 2025 $886
Food & beverage: $886
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $205 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $98 |
| Amgen Inc. | 5 | $84 |
| Lilly USA, LLC | 4 | $77 |
| GlaxoSmithKline, LLC. | 3 | $72 |
| PFIZER INC. | 3 | $56 |
| SANOFI-AVENTIS U.S. LLC | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Corcept Therapeutics | 2 | $37 |
| Exact Sciences Corporation | 2 | $34 |
Products named: Ozempic, Kerendia, MOUNJARO, Wegovy, OTEZLA, TRELEGY ELLIPTA, TZIELD, ELIQUIS.
Industry payments across FL — which companies pay providers there.
